Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows

Phase 2 Unknown 200 enrolled First Affiliated Hospital Xi'an Jiaotong University

RandomizedParallel-groupSingle-blindTreatment

Summary

To explore the safety and efficacy of edaravone dexborneol for patients of acute ischemic stroke received endovascular therapy in extended time windows.

Timeline

Start: 2021-10-01
Primary completion: 2022-12-01
Completion: 2022-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Edaravone Dexborneol	Unknown	37.5 mg	Intravenous

Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows

Summary

Timeline

Drugs

Indications